New Alzheimer’s Treatments and Tests Offer Hope but Leave Key Questions Unanswered
Source: www.washingtonpost.com Key Points: New drugs slow Alzheimer’s but have risks. Blood tests allow early detection. Lifestyle changes may help prevent it. Recent medical advances in Alzheimer’s Treatments have offered patients with Alzheimer’s disease new reasons for optimism, with two breakthrough drugs and a simple blood test raising hopes of slowing or detecting the condition earlier. Yet experts caution that questions remain about safety, access, and whether a true cure is still far off. Alzheimer’s accounts for about 70 percent of dementia cases globally and remains one of the leading causes of death among older adults. This year’s World Alzheimer’s Day, observed on Sunday, highlights both the progress and the uncertainty surrounding treatment and diagnosis. Drugs Show Promise but Spark Debate After decades of research and billions of dollars invested, two new Alzheimer’s Treatments, Eli Lilly’s donanemab and Biogen and Eisai’s lecanemab, sold under the brand name Leqem...